AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 87 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,861,600 | +332.9% | 260,000 | +203.2% | 0.10% | +284.0% |
| Q3 2022 | $430,000 | -77.7% | 85,758 | -89.1% | 0.02% | -77.7% |
| Q2 2022 | $1,926,000 | +62.4% | 789,181 | +347.9% | 0.11% | +202.7% |
| Q2 2021 | $1,186,000 | -44.0% | 176,206 | -24.7% | 0.04% | -38.3% |
| Q1 2021 | $2,116,000 | -18.7% | 234,122 | -39.9% | 0.06% | -36.8% |
| Q4 2020 | $2,602,000 | -35.1% | 389,571 | -51.0% | 0.10% | -54.1% |
| Q3 2020 | $4,008,000 | -11.9% | 795,200 | +41.3% | 0.21% | -52.6% |
| Q2 2020 | $4,547,000 | +15.3% | 562,800 | +13.3% | 0.44% | -6.6% |
| Q1 2020 | $3,943,000 | +379.1% | 496,660 | +355.7% | 0.47% | +550.0% |
| Q4 2019 | $823,000 | +63.0% | 109,000 | -10.2% | 0.07% | -16.3% |
| Q3 2019 | $505,000 | – | 121,435 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |